关闭
Column Subscription
Your position:www.healthoo.com >> EN >> EN >> Pharmaceutical News >> North China Pharmaceutical's Enzymatic Process Cefradine API Approved for Market Launch >> article
 
North China Pharmaceutical's Enzymatic Process Cefradine API Approved for Market Launch
Editor:xuezhe     Clicks:0    Date:2026/11/20 17:41:01
Keyword: API
Healthoo Information:
North China Pharmaceuticals Enzymatic Process Cefradine API Approved for Market Launch
 
 E-mail:xuezhe@healthoo.com
 Tel.:86-10-68012929
  Our services:
 China Im\Ex data service
 Service fees of Chinese Vision
 Our service items
Online information introduction
Monthly information
Relative Information
  • Weekly Review of Domestic API Market Highlights (Week 45, 2026)
  • Weekly Review of Domestic API Market Highlights (Week 44, 2026)
  • Analysis of the Global Development of Active Pharmaceutical Ingredient...
  • Weekly Update on Domestic API Market Conditions (Week 17 of 2026)
  • Weekly Update on Domestic API Market Trends (Week 10, 2026)
  • Weekly Update on Domestic Raw Material Drug Market Trends (Week 9, 202...
  • Weekly Update on Domestic Raw Material Drug Market Trends (Week 4, 202...
  • Weekly Review of Domestic Active Pharmaceutical Ingredients Market Tre...
  • Weekly Review of Domestic Active Pharmaceutical Ingredients Market (We...
  • Weekly Review of Domestic Active Pharmaceutical Ingredients Market Tre...
  • Address: Suite 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
    Tel:+86-10-68032463